Stonegate Healthcare Partners Announces Publication of Thematic Report on Anti-Aging Dermatology Innovations

Companies highlighted in this report are: SkinMedica, SK-II, Sirona Biochem (TSXV:SBM), One Skin, and CTEK Sisley.

Key Takeaways

  • Emerging novel topicals: Innovations like OneSkin’s OS-01, Sirona Biochem’s GlycoProteMim™, and SK-II’s Pitera™ offer signficant benefits that will let them take market share away from existing treatments
  • Personalized and holistic skincare: Advances ingenomics, skin diagnostics, and AI-driven tools enable tailored treatment plans ushering in a new era of skincare
  • Companies highlighted in this report are: SkinMedica, SK-II, Sirona Biochem (TSXV:SBM), One Skin, and CTEK Sisley.

Dallas, TX – June 18th, 2024 – Stonegate Healthcare Partners, a leading name in healthcare consultancy and market intelligence, is pleased to announce the publication of a comprehensive thematic report titled "Leading Innovations in Anti-Aging Dermatology". This report delves into the transformative advancements in the treatment of age-related skin conditions, focusing on cutting-edge technologies and personalized holistic approaches that are poised to revolutionize the skincare industry.

The landscape of treating age-related skin problems is set for a revolutionary shift, blending cutting-edge technology with personalized and holistic approaches. This evolution promises more effective, targeted, and safer treatments, allowing individuals to maintain youthful, healthy skin well into their advanced years. We are especially excited about advanced novel topicals like OneSkin’s OS-01, Sirona Biochem’s GlycoProteMim™ and SK-II’s Pitera™ which we believe will continue to take share from Retinoids, Toxins and Dermal fillers which have been entrenched in the market.


About Stonegate Healthcare Partners
Our mission at Stonegate Healthcare Partners is to accelerate meaningful innovations in healthcare through Strategy, Market Intelligence, Business Development, and Investor Outreach. The firm's research approach is centered on comprehensive and comparative analyses in specific healthcare fields. We strive to pinpoint programs that align closely with our strategic vision for the space and focus on technologies with the greatest potential for disruption. Stonegate Healthcare builds on its foundational thematic research by continuously gathering market intelligence, further enabling a current understanding of unmet needs and emerging disruptive technologies. 

Key Takeaways

  • Emerging novel topicals: Innovations like OneSkin’s OS-01, Sirona Biochem’s GlycoProteMim™, and SK-II’s Pitera™ offer signficant benefits that will let them take market share away from existing treatments
  • Personalized and holistic skincare: Advances ingenomics, skin diagnostics, and AI-driven tools enable tailored treatment plans ushering in a new era of skincare
  • Companies highlighted in this report are: SkinMedica, SK-II, Sirona Biochem (TSXV:SBM), One Skin, and CTEK Sisley.

Media Gallery

Related Bios

Shiv Kapoor
Co-Founder of Stonegate Healthcare Partners
Shiv is a Co-Founder of Stonegate Healthcare and is a biotech veteran with over 25 years of experience in investments and the development of Oncology therapeutics. He has been rated among the top three biotechnology analysts by Forbes in the US. Shiv ran the Smith Barney Biotech fund at Citigroup and started Sellside Biotech practices at Montgomery & Co. and Morgan Joseph. His opinion on the US Biotechnology sector has been widely quoted in leading US media including CNN, CNBC, Bloomberg, and Barron’s Guide. In the past decade, Shiv led investor relations and corporate strategy at Spectrum pharmaceuticals. In 2020 he founded BioRamon Pharmaceuticals, a biopharmaceutical company involved in early discovery and research of oncology medicine. Shiv has a BA in Biochemistry from UC Berkeley and an MBA from the University of Chicago Booth School of Business.
View Full Bio>>

Contacts

Shiv Kapoor
shiv@stonegateinc.com
Co-founder of Stonegate Healthcare Partners